Deutsche Bank Aktiengesellschaft upgraded shares of Boliden AB (publ) (OTCMKTS:BDNNY – Free Report) from a hold rating to a buy rating in a research report sent to investors on Tuesday morning, FlyOnTheWall reports.
Other analysts also recently issued research reports about the company. Barclays upgraded Boliden AB (publ) from an equal weight rating to an overweight rating in a research note on Monday, July 10th. Berenberg Bank downgraded Boliden AB (publ) from a buy rating to a hold rating in a research note on Friday, May 19th. DNB Markets downgraded Boliden AB (publ) from a buy rating to a hold rating in a research note on Wednesday, June 14th. Morgan Stanley upgraded Boliden AB (publ) from an underweight rating to an equal weight rating in a research note on Wednesday, June 21st. Finally, Sanford C. Bernstein upgraded Boliden AB (publ) from a market perform rating to an outperform rating in a research note on Tuesday, July 4th. Two equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat, Boliden AB (publ) currently has a consensus rating of Hold and an average target price of $368.75.
Boliden AB (publ) Trading Up 0.4 %
Boliden AB (publ) (OTCMKTS:BDNNY – Get Free Report) last posted its earnings results on Thursday, July 20th. The company reported $0.36 earnings per share for the quarter. The firm had revenue of $1.75 billion for the quarter.
Boliden AB (publ) Company Profile
Boliden AB (publ) engages in the exploring, extracting, and processing of base metals and precious metals in Sweden, other Nordic region, Germany, the United Kingdom, the rest of Europe, North America, and internationally. The company operates through two segments, Business Area Mines and Business Area Smelters.
- Five stocks we like better than Boliden AB (publ)
- Investing in Agriculture 101: How to Invest in Agriculture
- 5 Ways to Play Retail that will Profit in 2023
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- This Is Why It’s Not Too Late For You To Buy Meta Stock
- The How and Why of Investing in Biotech Stocks
- Why Analysts Say GE’s Healthcare Spinoff Has $20 Upside
Receive News & Ratings for Boliden AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Boliden AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.